CervoMed
CRVO
19 hedge funds and large institutions have $2.34M invested in CervoMed in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 6 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.01% less ownership
Funds ownership: 0.13% → 0.12% (-0.01%)
5% less funds holding
Funds holding: 20 → 19 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
20% less capital invested
Capital invested by funds: $2.94M → $2.34M (-$598K)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$26.8K |
| 2 |
LPL Financial
San Diego,
California
|
+$19.3K |
| 3 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$5.42K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$4.09K |
| 5 |
JP Morgan Chase
New York
|
+$2.24K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$158K |
| 2 |
VF
Virtu Financial
New York
|
-$46K |
| 3 |
Two Sigma Advisers
New York
|
-$15.6K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$13.9K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$6K |
CRVO Hedge Fund Activity: Q1 2022 in Review
19 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q1 2022, worth a combined $2.34M — down 20% from $2.94M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of CRVO and 5 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 2 added.
The largest buyer was Renaissance Technologies, adding an estimated $26.8K. The largest seller was Vanguard Group, cutting an estimated $158K.
- 19 institutional investors held CervoMed (CRVO) as of Q1 2022, down from 20 in Q4 2021.
- Funds reported $2.34M of CervoMed stock for Q1 2022, down 20% quarter-over-quarter.
- 5 funds opened new CervoMed positions in Q1 2022 and 6 closed out, a net change of -1 holder.
- The largest CervoMed buyer in Q1 2022 was Renaissance Technologies, an estimated $26.8K added.
- The largest CervoMed seller in Q1 2022 was Vanguard Group, an estimated $158K sold.
Based on aggregated 13F filings for Q1 2022.